US2012302794A1PendingUtilityA1
Derivatives of venlafaxine and methods of preparing and using the same
Individually held — no corporate assignee on recordPriority: Apr 6, 1999Filed: Aug 9, 2012Published: Nov 29, 2012
Est. expiryApr 6, 2019(expired)· nominal 20-yr term from priority
A61P 9/10A61P 43/00A61P 25/06A61P 25/24A61P 25/04A61P 3/04A61P 25/16A61P 25/00A61P 25/20A61P 25/28A61P 25/14A61P 25/08A61P 25/30A61P 25/22C07C 217/74A61P 13/00A61K 9/2059A61K 31/135C07C 255/37C07C 215/64C07C 233/18C07C 2601/14A61P 23/00C07C 255/36A61K 9/4866A61K 9/2054A61P 15/10C07D 295/192
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods of preparing, and compositions comprising, derivatives of venlafaxine are disclosed. Also disclosed are methods of treating and preventing diseases and disorders including, but not limited to, affective disorders such as depression, bipolar and manic disorders, attention deficit disorder, attention deficit disorder with hyperactivity, Parkinson's disease, epilepsy, cerebral function disorders, obesity and weight gain, incontinence, dementia and related disorders.
Claims
exact text as granted — not AI-modified1 - 59 . (canceled)
60 . A compound which is O-desmethylvenlafaxine succinate.Join the waitlist — get patent alerts
Track US2012302794A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.